期刊文献+

野生型p16和p53抑癌基因共转染对K562细胞增殖的抑制作用 被引量:3

Inhibition of K562 Cell Proliferation by Wild Type p16 and p53 Genes Cotransfection
在线阅读 下载PDF
导出
摘要 抑癌基因p1 6和 p53在抑制肿瘤的发生中起重要作用 ,在髓细胞白血病细胞系K562中检测出这两种基因有纯合缺失。为探讨野生型 p1 6和 p53基因的转染与表达对K562细胞的生长影响 ,采用了脂质体介导外源野生型 p1 6和 p53共转染K562细胞 ,用免疫细胞化学染色检测p1 6和 p53基因的表达 ,检测细胞生长曲线 ,采用流式细胞术进行细胞周期分析。结果显示 ,共转染后 p53和p1 6在K562细胞中表达阳性率分别为 2 3 %和 2 8% ;细胞生长受到一定程度的抑制 ,G1 期细胞的比例增加 ,S期细胞减少 ,与单独转染 p53或p1 6基因的抑制作用有明显差别 (P <0 .0 5)。结论 :外源野生型 p1 6和p53基因的共转染比转染单基因对K562细胞生长有更明显的抑制作用 。 The Tumor suppressor gene p53 and p16, both of which play an important role in inhibition of tumorigenesis, are homozygously deleted in human myeloid leukemia cell line K562. To explore the inhibition of K562 cell proliferation by wild type p16 and p53 genes, both p16 and p53 genes were cotransfected into K562 cells mediated by liposome. The expression of the two genes was measured by immunocytochemical method, the cell cycle was analysed by flow cytometry, and the number of recovered viable cells was assessed after transfection. After cotransfection, the p53 and p16 positive cells were 23% and 28%, respectively. The results showed that cotransfection of p16 and p53 genes significantly inhibits cell proliferation comparing with transfection either by p16 gene or by p53 gene (P<0.05). Expression of p16 and p53 proteins increased the cell number in G 1 phase but decreased the cell number in S phase. It is concluded that cotransfection of p16 and p53 genes has a stronger growth inhibitory effect on K562 cell growth than that of transfection only by p16 gene or by p53 gene, may be a pathway for gene therapy in leukemia.
出处 《中国实验血液学杂志》 CAS CSCD 2002年第5期400-403,共4页 Journal of Experimental Hematology
关键词 P16基因 p53基因 抑癌基因 基因共转染 K562细胞系 白血病 基因治疗 细胞增殖 p16 gene p53 gene tumor suppressor gene gene cotransfection K562 cell line
  • 相关文献

参考文献11

  • 1Selter H, Montenarh M. The emerging picture of p53. Int J Biochem, 1994; 26:145 - 154
  • 2Nielsen LL, Maneval DC. P53 tumor suppressor gene therapy for cancer. Cancer Gene Ther, 1998; 5:52 - 63
  • 3Ruas M, Brookes S, McDonald NQ, et al. Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information. Oncogene, 1999; 18:5423 - 5434
  • 4Serrano M, Hannon GJ and Beach DA. A new regulatory motif in cell-cycle causing specific inhibition of cyclin D/CDK4. Nature, 1993; 366:704 - 707
  • 5Quesnel B, Preudhomme C, Lepelley P, et al. Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation. Br J Heamatol, 1996; 95:291 - 298
  • 6Rizzo MG, Zepparoni A, Cristofanelli B, et al. Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation. Br J Cancer, 1998; 77:1429- 1438
  • 7Pinyol M, Cobo F, Bea S, et al. p16INK4a gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin s lymphomas.Blood, 1998; 91:2977 - 2984
  • 8Stock W, Tsai T, Golden C, et al. Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia. Blood, 2000; 95:2364 - 2371
  • 9Kinoshita I, Dosaka-Akita H, Mishina I, et al. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.Cancer Res, 1996; 56:5557 - 5562
  • 10Zhuo Y, Yi H, Gu HH, et al. Alterations of the p16 gene in nasopharyngeal carcinogenesis. Chinese Medical Journal, 2000; 113:48

同被引文献29

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部